2017 has been full of new discoveries that will influence the treatment of colorectal cancer. In the adjuvant setting, 3 months of chemotherapy might now be considered a new standard of care. Various other new treatments and promising biomarkers have also become available that will improve survival outcomes and the quality of life of many patients with metastatic disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491976 | PMC |
http://dx.doi.org/10.1038/nrclinonc.2017.185 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!